This Solicitation opportunity from Government of Canada was posted on January 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
RFP PHSA 16956 Provincial Retinal Diseases Treatment Program (PRDTP) Pharmacy Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Provincial Health Services Authority (PHSA) has issued a Request for Proposals (RFP) to secure a supplier or multiple suppliers for single-use intravitreal prefilled syringes containing anti-vascular endothelial growth factor (anti-VEGF) drugs. These syringes are intended for ophthalmic treatments provided through the Provincial Retinal Diseases Treatment Program (PRDTP), a PHSA initiative. The contract is non-exclusive, allowing for multiple proponents to be selected, and covers supply to specific program clinics outlined in the RFP documentation. Interested proponents must respond by the deadline of March 6, 2026. The procurement is managed by PHSA, operating under the Government of Canada, and communication is conducted through the designated Contracting Authority via email. The RFP aims to support the delivery of specialized retinal disease treatments by ensuring a reliable supply of necessary pharmaceutical products to PRDTP clinics.
General Info
Agency
NAICS
Place of Performance
CANSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
